TGFBR3 and cancer: Consistently, our study revealed that the TGF-β signaling pathway was implicated in the effect of miR-501-3p-mediated downregulation of TGFBR3 on PDAC cells, which indicated a conserved anti-oncogenic role of TGFBR3 in combination with results in other cancers.